Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Nasopharyngeal Neoplasms × sintilimab × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 6 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Nasopharyngeal Carcinoma 2 Squamous NSCLC 1 Squamous Cell Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Resectable Non-small Cell Lung Cancer 1 Radiation Pneumonitis 1 Non-Squamous Non-Small Cell Lung Cancer 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 MSI-H 1 Lung Neoplasms 1 HER2+ Breast Cancer 1 Gastrointestinal Diseases 1 Esophageal Diseases 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Advanced Non-squamous Non-Small-Cell Lung Cancer 1

Interventions

Gemcitabine 11 Cisplatin 11 Radiotherapy, Intensity-Modulated 6 tislelizumab 2 nimotuzumab 2 camrelizumab 2 Fluorouracil 2 Carboplatin 2 spartalizumab 1 sintilimab 1 sargramostim 1 pembrolizumab 1 fosaprepitant 1 etoposide phosphate 1 Tropisetron 1 Radiotherapy 1 Induction Chemotherapy 1 Ifosfamide 1 Etoposide 1 Docetaxel 1 Dexamethasone 1 Chemotherapy, Adjuvant 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03700476 2023-03-28

CONTINUUM

Sun Yat-sen University

Phase 3 Unknown

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡